157 related articles for article (PubMed ID: 19296128)
1. Semaphorin3A immunohistochemical expression in human meningiomas: correlation with the microvessel density.
Barresi V; Vitarelli E; Cerasoli S
Virchows Arch; 2009 May; 454(5):563-71. PubMed ID: 19296128
[TBL] [Abstract][Full Text] [Related]
2. Increased ratio of vascular endothelial growth factor to semaphorin3A is a negative prognostic factor in human meningiomas.
Barresi V; Tuccari G
Neuropathology; 2010 Oct; 30(5):537-46. PubMed ID: 20337947
[TBL] [Abstract][Full Text] [Related]
3. Sstr2A immunohistochemical expression in human meningiomas: is there a correlation with the histological grade, proliferation or microvessel density?
Barresi V; Alafaci C; Salpietro F; Tuccari G
Oncol Rep; 2008 Sep; 20(3):485-92. PubMed ID: 18695896
[TBL] [Abstract][Full Text] [Related]
4. p-CREB expression in human meningiomas: correlation with angiogenesis and recurrence risk.
Barresi V; Branca G; Caffo M; Tuccari G
J Neurooncol; 2015 Mar; 122(1):87-95. PubMed ID: 25563814
[TBL] [Abstract][Full Text] [Related]
5. Density of microvessels positive for CD105 (endoglin) is related to prognosis in meningiomas.
Barresi V; Cerasoli S; Vitarelli E; Tuccari G
Acta Neuropathol; 2007 Aug; 114(2):147-56. PubMed ID: 17594108
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of neo-angiogenesis in a case of chordoid meningioma.
Barresi V; Tuccari G
J Neurooncol; 2009 Dec; 95(3):445-447. PubMed ID: 19557500
[TBL] [Abstract][Full Text] [Related]
7. Correlative evidence that tumor cell-derived caveolin-1 mediates angiogenesis in meningiomas.
Barresi V; Cerasoli S; Tuccari G
Neuropathology; 2008 Oct; 28(5):472-8. PubMed ID: 18282163
[TBL] [Abstract][Full Text] [Related]
8. Expression of cell adhesion proteins and proteins related to angiogenesis and fatty acid metabolism in benign, atypical, and anaplastic meningiomas.
Panagopoulos AT; Lancellotti CL; Veiga JC; de Aguiar PH; Colquhoun A
J Neurooncol; 2008 Aug; 89(1):73-87. PubMed ID: 18418552
[TBL] [Abstract][Full Text] [Related]
9. MMP-9 expression in meningiomas: a prognostic marker for recurrence risk?
Barresi V; Vitarelli E; Tuccari G; Barresi G
J Neurooncol; 2011 Apr; 102(2):189-96. PubMed ID: 20652360
[TBL] [Abstract][Full Text] [Related]
10. DNA topoisomerase II-alpha and cyclin A immunoexpression in meningiomas and its prognostic significance: an analysis of 263 cases.
Korshunov A; Shishkina L; Golanov A
Arch Pathol Lab Med; 2002 Sep; 126(9):1079-86. PubMed ID: 12204057
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor, hepatocyte growth factor/scatter factor, basic fibroblast growth factor, and placenta growth factor in human meningiomas and their relation to angiogenesis and malignancy.
Lamszus K; Lengler U; Schmidt NO; Stavrou D; Ergün S; Westphal M
Neurosurgery; 2000 Apr; 46(4):938-47; discussion 947-8. PubMed ID: 10764269
[TBL] [Abstract][Full Text] [Related]
12. The density of microvessels positive for Wilms' tumour-1 protein (WT-1) is an independent predictor of recurrence risk in meningiomas.
Barresi V; Caffo M; Branca G; Vitarelli E; Tuccari G
Brain Tumor Pathol; 2015 Jul; 32(3):202-9. PubMed ID: 25773860
[TBL] [Abstract][Full Text] [Related]
13. Correlations of magnetic resonance, perfusion-weighed imaging parameters and microvessel density in meningioma.
Shi R; Jiang T; Si L; Li M
J BUON; 2016; 21(3):709-13. PubMed ID: 27569094
[TBL] [Abstract][Full Text] [Related]
14. Basic fibroblast growth factor and fibroblast growth factor receptor-i in human meningiomas.
Yi W; Chen J; Golwa FH; Xue D
J Huazhong Univ Sci Technolog Med Sci; 2005; 25(1):75-7. PubMed ID: 15934314
[TBL] [Abstract][Full Text] [Related]
15. Angiogenesis in intracranial meningiomas: immunohistochemical and molecular study.
Pistolesi S; Boldrini L; Gisfredi S; De Ieso K; Camacci T; Caniglia M; Lupi G; Leocata P; Basolo F; Pingitore R; Parenti G; Fontanini G
Neuropathol Appl Neurobiol; 2004 Apr; 30(2):118-25. PubMed ID: 15043709
[TBL] [Abstract][Full Text] [Related]
16. Correlation between histological grade, MIB-1, p53, and recurrence in 69 completely resected primary intracranial meningiomas with a 6 year mean follow-up.
Lanzafame S; Torrisi A; Barbagallo G; Emmanuele C; Alberio N; Albanese V
Pathol Res Pract; 2000; 196(7):483-8. PubMed ID: 10926326
[TBL] [Abstract][Full Text] [Related]
17. Microvascularization of Grade I meningiomas: effect on tumor volume, blood loss, and patient outcome.
Karsy M; Burnett B; Di Ieva A; Cusimano MD; Jensen RL
J Neurosurg; 2018 Mar; 128(3):657-666. PubMed ID: 28362240
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of EGFR expression in de novo and progressed atypical and anaplastic meningiomas: an immunohistochemical and fluorescence in situ hybridization pilot study.
Caltabiano R; Barbagallo GM; Castaing M; Cassenti A; Senetta R; Cassoni P; Albanese V; Lanzafame S
J Neurosurg Sci; 2013 Jun; 57(2):139-51. PubMed ID: 23486338
[TBL] [Abstract][Full Text] [Related]
19. Embolized meningiomas: risk of overgrading and neo-angiogenesis.
Barresi V; Branca G; Granata F; Alafaci C; Caffo M; Tuccari G
J Neurooncol; 2013 Jun; 113(2):207-19. PubMed ID: 23504284
[TBL] [Abstract][Full Text] [Related]
20. MCM7 expression is a promising predictor of recurrence in patients surgically resected for meningiomas.
Winther TL; Torp SH
J Neurooncol; 2017 Feb; 131(3):575-583. PubMed ID: 27868157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
